February 27, 2020 / 11:58 AM / a month ago

BRIEF-Pre-clinical Studies Demonstrate CBD’s Robust Anti-Cancer Effect Against Liver Cancer

Feb 27 (Reuters) - Can Fite Biopharma Ltd:

* PRE-CLINICAL STUDIES DEMONSTRATE CBD’S ROBUST ANTI-CANCER EFFECT AGAINST LIVER CANCER; CAN-FITE AND UNIVO PHARMACEUTICALS EXPAND COLLABORATION AGREEMENT

* CAN FITE BIOPHARMA LTD - IN PRE-CLINICAL STUDIES, CBD ENRICHED FRACTIONS INDUCED ANTI-LIVER CANCER EFFECT AT MINUTE CONCENTRATIONS

* CAN FITE BIOPHARMA LTD - EXPANSION OF AGREEMENT ALLOWS CAN-FITE TO DEVELOP 2 ADDITIONAL CLINICAL INDICATIONS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below